ChomiX Biotech
If you are struggling with drug innovation, don't miss ChomiX's chemical proteomics
Founded and officially operated since 2021, ChomiX Biotech Co., Ltd is a pioneering biotechnology company dedicated to the preclinical R&D of innovative small molecule drugs. Leveraging cutting-edge chemoproteomics as our core technology, we specialize in the novel lead compound screening and the discovery of new targets for active drug molecules within living cell systems.
ChomiX has formed partnerships with dozens of small molecule drug R&D companies as well as with hundreds of research groups from leading universities and hospitals, such as Peking University, Nanjing University, Sun Yat-sen University, and China Pharmaceutical University.
We are committed to rapidly breaking through the undruggable barriers of disease targets and accelerating the discovery of new drugs.
